de Janeiro since 1995 and started to work at the Int Braz J Urol in 1999 as a reviewer, invited by Professor Francisco J. B. Sampaio. During this time I have learned a lot from the latest editors and could witness the growth of our journal. Today, the journal is well established and can be considered one of the most respected journals in the urological community.
Banno and collegues from Japan (4) present on page 26 an interesting study about computed tomography imaging characteristics of clear cell papillary renal cell carcinoma (CCP), a new subtype of Renal cell carcinoma (RCC) recognized in 2013. The authors studied 12 patients pathologically diagnosed with CCP RCC and concluded that the CT imaging characteristics of CCP RCCs could be categorized into either solid or cystic type.
Dr. Johnston and colleagues from USA (5) performed on page 42 an external validation study about bone scan positivity in non-metastatic, castrate-resistant prostate cancer. The authors performed a retrospective cohort study of 6,509 patients with non-metastatic, castrate-resistant prostate cancer and concluded that previously published risk tables predicted bone scan positivity in men with non--metastatic, castrate-resistant prostate cancer with reasonable accuracy.
Balaban and colleagues from Turkey (6) present on page 60 an interesting study about acute prostatitis after prostate biopsy under ciprofl oxacin prophylaxis with or without ornidazole and pre--biopsy enema in 3,479 cases and concluded that repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential.
Dr. Li and colleagues from China (7) performed on page 92 an amazing study about the role of contrast-enhanced ultrasound (CEUS) in differentiating bland thrombus from tumor thrombus of the inferior vena cava (IVC) in patients with renal cell carcinoma (RCC) in 30 patients who underwent robot-assisted radical nephrectomy with IVC thrombectomy and pathologically confi rmed RCC and concluded that CEUS is an effective, inexpensive, and non-invasive method, that could be a reliable tool in the evaluation of IVC thrombus in patients with RCC.
We hope that readers will enjoy the changes made and read and publicize the International Brazilian Journal of Urology.
